Trial intelligence / Profile preview

Azathioprine lozenge for oral lichen planus

IRCT20191106045356N10Phase 3Completed

Sponsor
Shahid Sadoughi University of Medical Sciences
Start
Jan 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of azathioprine in oral lichen planus (OLP), sponsored by Shahid Sadoughi University of Medical Sciences. Started Jan 2022; status: completed.

02

Drugs

azathioprine
03

Conditions

oral lichen planus (OLP)

Beyond the preview

Go deeper on IRCT20191106045356N10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20191106045356N10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call